Spectral Medical Inc.
EDTXF
$0.99
$0.022.04%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.90% | 31.23% | 29.28% | 22.06% | 40.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.90% | 31.23% | 29.28% | 22.06% | 40.94% |
| Cost of Revenue | -31.69% | -15.34% | -8.85% | 24.04% | 68.38% |
| Gross Profit | 90.92% | 155.11% | 130.80% | 17.89% | 1.86% |
| SG&A Expenses | -0.39% | -0.72% | -0.84% | 9.26% | 3.25% |
| Depreciation & Amortization | -76.03% | -78.33% | -78.74% | 111.17% | 175.29% |
| Other Operating Expenses | 38.79% | 11.26% | -7.40% | -10.25% | -30.05% |
| Total Operating Expenses | -7.19% | -5.90% | -5.66% | 12.43% | 10.84% |
| Operating Income | 9.48% | 11.88% | 10.96% | -11.01% | -6.53% |
| Income Before Tax | -200.93% | -62.96% | -10.67% | -24.10% | 0.95% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -200.93% | -62.96% | -10.67% | -24.10% | 0.95% |
| Earnings from Discontinued Operations | 58.82% | 79.42% | 95.87% | 94.10% | 95.54% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -200.81% | -62.77% | -9.74% | -23.38% | 1.88% |
| EBIT | 9.48% | 11.88% | 10.96% | -11.01% | -6.53% |
| EBITDA | 9.55% | 12.10% | 11.09% | -11.01% | -6.49% |
| EPS Basic | -194.09% | -59.30% | -8.03% | -21.77% | 2.40% |
| Normalized Basic EPS | -175.59% | -72.25% | -13.09% | -26.85% | -2.83% |
| EPS Diluted | -194.09% | -59.30% | -8.03% | -21.77% | 2.40% |
| Normalized Diluted EPS | -175.59% | -72.25% | -13.09% | -26.85% | -2.83% |
| Average Basic Shares Outstanding | 2.10% | 1.82% | 1.63% | 1.33% | 0.94% |
| Average Diluted Shares Outstanding | 2.10% | 1.82% | 1.63% | 1.33% | 0.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |